Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Shockwave Medical

J&J’s Shockwave shares data supporting Javelin forward IVL

By

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results in a study using its Javelin peripheral IVL catheter. Yesterday, the company shared findings from a separate intravascular lithotripsy (IVL) study. It presented findings at the annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Today, it shared … [Read more...] about J&J’s Shockwave shares data supporting Javelin forward IVL

J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI

By

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral IVL system. Shockwave shared findings from DISRUPT BTK II. The post-market study evaluates the safety and effectiveness of the company's intravascular lithotripsy (IVL) system for the treatment of calcified lesions … [Read more...] about J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI

J&J’s Shockwave launches Javelin IVL catheter in Europe

By

Johnson & Johnson MedTech‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe. The novel, non-balloon catheter comprises part of the company's first-of-its-kind forward intravascular lithotripsy (IVL) platform. It features a similar safety and effectiveness profile to legacy Shockwave IVL … [Read more...] about J&J’s Shockwave launches Javelin IVL catheter in Europe

J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women

By

  Johnson & Johnson MedTech‘s Shockwave Medical unit today announced study results highlighting the use of its IVL treatment in female patients. Shockwave announced 30-day primary endpoint results from the EMPOWER CAD study of its intravascular lithotripsy (IVL) therapy. It marks the first prospective, real-world percutaneous … [Read more...] about J&J’s Shockwave touts study highlighting the use of IVL-first strategy for women

J&J’s Shockwave enrolls first patient in novel forward IVL study

By

Johnson & Johnson MedTech‘s Shockwave Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter. FORWARD CAD, an FDA investigational device exemption (IDE) study, evaluates the safety and efficacy of the company's latest intravascular lithotripsy (IVL) catheter. It aims to treat calcified, … [Read more...] about J&J’s Shockwave enrolls first patient in novel forward IVL study

How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach

By

Shockwave’s novel Javelin intravascular lithotripsy catheter focuses acoustic energy forward to clear a path through calcium-clogged blood vessels. Johnson & Johnson MedTech’s Shockwave Medical aims to deliver intravascular lithotripsy (IVL) to a different type of blood vessel with a first-of-its-kind catheter platform. The Javelin … [Read more...] about How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach

J&J’s Shockwave Medical launches new IVL catheter

By

Johnson & Johnson MedTech‘s Shockwave Medical today announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter. The system is designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-balloon IVL platform delivers a similar … [Read more...] about J&J’s Shockwave Medical launches new IVL catheter

Shockwave Medical’s Javelin IVL catheter meets primary trial endpoints

By

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin catheter. Shockwave shared the first clinical outcomes associated with its Javelin peripheral intravascular lithotripsy (IVL) catheter system. It designed this novel, non-balloon-based lithotripsy platform to modify … [Read more...] about Shockwave Medical’s Javelin IVL catheter meets primary trial endpoints

J&J’s Shockwave adds enhanced catheter to U.S. IVL portfolio

By

Johnson & Johnson MedTech's Shockwave Medical today announced the full U.S. launch of its Shockwave E8 peripheral IVL catheter. Santa Clara, California-based Shockwave launched the intravascular lithotripsy (IVL) catheter following FDA clearance. It designed the catheter to optimize the treatment of patients with calcified femoro-popliteal … [Read more...] about J&J’s Shockwave adds enhanced catheter to U.S. IVL portfolio

Shockwave Medical launches new coronary IVL catheter following FDA approval

By

Shockwave Medical announced today that it unveiled a new coronary intravascular lithotripsy (IVL) catheter in the U.S. The planned introduction of the Shockwave C2+ coronary IVL catheter follows the receipt of FDA approval. This catheter offers 50% more pulses per catheter than the Shockwave C2 catheter that the FDA approved in June … [Read more...] about Shockwave Medical launches new coronary IVL catheter following FDA approval